Lotus Labs, a Bangalore-based contract research organisation (CRO), has moved into the sphere of drug stability studies, which measure how the quality of a drug substance varies with time under the influence of temperature, humidity and light. | |
| "After building skills in bio-analytical, clinical research, we are now fully geared to take up drug stability studies for pharmaceutical companies," said Sudhir Pai, director commercial at Lotus Labs. |
| |
| Currently, the company plans to take up stability studies for its parent company Iceland-based Actavis group, which is the fourth largest generic pharmaceutical company. |
| |
| "After stabilising the operations in another 6-8 months, we plans to take up third party assignments," he added. |
| |
|
| |
